SJS Investment Consulting’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

SJS Investment Consulting’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22	Closed	-$397	–	1690
2025 Q1	$397	Hold	22	–	–	﹤0.01%	1319
2024 Q4	$385	Sell	22 -4	-15%	-$54	﹤0.01%	1330
2024 Q3	$300	Hold	26	–	–	﹤0.01%	1449
2024 Q2	$295	Hold	26	–	–	﹤0.01%	1437
2024 Q1	$373	Hold	26	–	–	﹤0.01%	1381
2023 Q4	$357	Buy	26 +8	+44%	+$84	﹤0.01%	1346
2023 Q3	$147	Buy	18 +3	+20%	+$25	﹤0.01%	1499
2023 Q2	$114	Buy	15 +12	+400%	+$92	﹤0.01%	1504
2023 Q1	$24	Sell	3 -13	-81%	-$134	﹤0.01%	1557
2022 Q4	$182	Sell	16 -19	-54%	-$207	﹤0.01%	1427
2022 Q3	$0	Buy	+35	New	+$363	﹤0.01%	1630
2022 Q1	$0	Buy	+1	New	+$11	﹤0.01%	1428

SJS Investment Consulting's PTVE Position: Q2 2025 in Review

SJS Investment Consulting sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 22 shares — an estimated $397 sold.

SJS Investment Consulting first reported a position in PTVE in Q1 2022 and held it in 12 quarters. The position peaked at $397 in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

SJS Investment Consulting reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
SJS Investment Consulting sold 22 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $397.
SJS Investment Consulting first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2022 and held it in 12 quarters.
SJS Investment Consulting's Pactiv Evergreen Inc. Common stock position peaked at $397 in Q1 2025.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on SJS Investment Consulting's 13F filing for Q2 2025, filed 15 Jul 2025.